摘要
Abstract
Objective To investigate the cost effectiveness of interventional therapy and drug conservative treatment in patients with acute non ST segment elevation myocardial infarction (NSTEMI).Methods Select the December January 2013 to 2014 Department of Cardiology;the second people's Hospital of Guangdong Province and Zhongshan University Sun Yat Sen Memorial heart medicine diagnosis of 153 patients with NSTEMI patients as the research object,the interventional treatment of 102 cases,51 cases underwent conservative treatment with drugs, using cost - effectiveness analysis of two therapeutic schemes in the treatment of clinical effect and medical cost ofpharmacoeconomic evaluation.Results The intervention group of hospitalized patients with recurrent angina,heart failure,arrhythmia and stroke were significantly lower than that in drug treatment group,the differences were statisticaly significant(P<0.05);the intervention group was significantly higher than the total cost of hospitali- zation in patients with conservative medical treatment group,the diference was statisticaly significant(P<0.05);1 years of folow-up,the intervention group of patients with cardiogenic mortality was significantly lower than the conservative treatment group,the incidence of the primary endpoint to avoid joint,the total cost was significantly higher than that in medicine group,the differences were statisticaly significant(P<0.05);cost effectiveness analysis showed that the intervention group was significantly higher than that of drug the conservative treatment group,the difference was statisticaly significant(P<0.05).Conclusion Interventional treatment has certain advantages,can reduce the incidence of hospitalization during adverse cardiovascular events and folowed up 1 year endpoint,but considered from the viewpoint of pharmaceutical economics,short-term drug conservative treatment is a better cost effectiveness than interventional treatment.关键词
急性非ST段抬高型心肌梗死/介入治疗/药物保守治疗/成本-效果分析Key words
Non-ST-segment elevation myocardial infarction/Invasive treatment/Conservative treatment/Cost- effectiveness analysis分类
医药卫生
